After a string of breaches involving anthrax, Ebola, and bird flu, the US Centers for Disease Control and Prevention has reportedly replaced the director of its Division of Select Agents and Toxins.

In the wake of a handful of biosafety lapses at federal research facilities, the US government is temporarily halting funding for new studies aiming to give novel functions to influenza, SARS, and MERS viruses.

Following recent high-profile safety lapses in government labs, the US Centers for Disease Control and Prevention has placed a moratorium on movement of biological materials from BSL-3 and BSL-4 facilities.

A person in Canada has died of the first confirmed human case of H5N1 avian flu in North America.

A group of scientists has called on the European Commission to evaluate the risks and benefits of research that could make deadly viruses more transmissible.

The US Food and Drug Administration OKs a vaccine against the virus that last year had the scientific community debating the regulation of deadly pathogen research.

Flu researchers propose H7N9 studies; NIH makes deal to share HeLa genome; herbal “remedies” can cause cancer; scientists record grid cell activity in humans

As new infections surface and spread, science meets the challenges with ingenuity and adaptation.

Hybrid viruses derived from an H5N1 bird flu strain can infect guinea pigs through the air.

After a year-long voluntary moratorium to discuss regulations and safety measures, scientists are set to resume controversial H5N1 research.